152 related articles for article (PubMed ID: 23053470)
1. Cross-sectional baseline analysis of electrocardiography in a large cohort of patients with untreated Fabry disease.
Niemann M; Hartmann T; Namdar M; Breunig F; Beer M; Machann W; Herrmann S; Ertl G; Wanner C; Weidemann F
J Inherit Metab Dis; 2013 Sep; 36(5):873-9. PubMed ID: 23053470
[TBL] [Abstract][Full Text] [Related]
2. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.
Niemann M; Herrmann S; Hu K; Breunig F; Strotmann J; Beer M; Machann W; Voelker W; Ertl G; Wanner C; Weidemann F
JACC Cardiovasc Imaging; 2011 Jun; 4(6):592-601. PubMed ID: 21679893
[TBL] [Abstract][Full Text] [Related]
3. The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy.
Schmied C; Nowak A; Gruner C; Olinger E; Debaix H; Brauchlin A; Frank M; Reidt S; Monney P; Barbey F; Shah D; Namdar M
Heart; 2016 Aug; 102(16):1309-14. PubMed ID: 27056970
[TBL] [Abstract][Full Text] [Related]
4. Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy.
Krämer J; Bijnens B; Störk S; Ritter CO; Liu D; Ertl G; Wanner C; Weidemann F
PLoS One; 2015; 10(11):e0140627. PubMed ID: 26600044
[TBL] [Abstract][Full Text] [Related]
5. Early detection of organ involvement in Fabry disease by biomarker assessment in conjunction with LGE cardiac MRI: results from the SOPHIA study.
Weidemann F; Beer M; Kralewski M; Siwy J; Kampmann C
Mol Genet Metab; 2019 Feb; 126(2):169-182. PubMed ID: 30594474
[TBL] [Abstract][Full Text] [Related]
6. Value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and Fabry disease.
Namdar M; Steffel J; Jetzer S; Schmied C; Hürlimann D; Camici GG; Bayrak F; Ricciardi D; Rao JY; de Asmundis C; Chierchia GB; Sarkozy A; Lüscher TF; Jenni R; Duru F; Brugada P
Am J Cardiol; 2012 Feb; 109(4):587-93. PubMed ID: 22105784
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Clinical Evolution in Prehypertrophic Fabry Disease.
Camporeale A; Pieroni M; Pieruzzi F; Lusardi P; Pica S; Spada M; Mignani R; Burlina A; Bandera F; Guazzi M; Graziani F; Crea F; Greiser A; Boveri S; Ambrogi F; Lombardi M
Circ Cardiovasc Imaging; 2019 Apr; 12(4):e008424. PubMed ID: 30943767
[TBL] [Abstract][Full Text] [Related]
8. The value of electrocardiography and echocardiography in distinguishing Fabry disease from sarcomeric hypertrophic cardiomyopathy.
Junqua N; Legallois D; Segard S; Lairez O; Réant P; Goizet C; Maillard H; Charron P; Milliez P; Labombarda F
Arch Cardiovasc Dis; 2020; 113(8-9):542-550. PubMed ID: 32771348
[TBL] [Abstract][Full Text] [Related]
9. Tei index in fabry disease.
Niemann M; Breunig F; Beer M; Hu K; Liu D; Emmert A; Herrmann S; Ertl G; Wanner C; Takenaka T; Tei C; Weidemann F
J Am Soc Echocardiogr; 2011 Sep; 24(9):1026-32. PubMed ID: 21719255
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Cardiac Magnetic Resonance Imaging and Echocardiography in Assessment of Left Ventricular Hypertrophy in Fabry Disease.
Hazari H; Belenkie I; Kryski A; White JA; Oudit GY; Thompson R; Fung T; Dehar N; Khan A
Can J Cardiol; 2018 Aug; 34(8):1041-1047. PubMed ID: 29935990
[TBL] [Abstract][Full Text] [Related]
11. ECG-based score estimates the probability to detect Fabry Disease cardiac involvement.
Figliozzi S; Camporeale A; Boveri S; Pieruzzi F; Pieroni M; Lusardi P; Spada M; Mignani R; Burlina A; Graziani F; Pica S; Tondi L; Bernardini A; Chow K; Namdar M; Lombardi M
Int J Cardiol; 2021 Sep; 339():110-117. PubMed ID: 34274410
[TBL] [Abstract][Full Text] [Related]
12. Apicobasal gradient of left ventricular myocardial edema underlies transient T-wave inversion and QT interval prolongation (Wellens' ECG pattern) in Tako-Tsubo cardiomyopathy.
Perazzolo Marra M; Zorzi A; Corbetti F; De Lazzari M; Migliore F; Tona F; Tarantini G; Iliceto S; Corrado D
Heart Rhythm; 2013 Jan; 10(1):70-7. PubMed ID: 22975421
[TBL] [Abstract][Full Text] [Related]
13. Relationship of ECG findings to phenotypic expression in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study.
Delcrè SD; Di Donna P; Leuzzi S; Miceli S; Bisi M; Scaglione M; Caponi D; Conte MR; Cecchi F; Olivotto I; Gaita F
Int J Cardiol; 2013 Aug; 167(3):1038-45. PubMed ID: 22464482
[TBL] [Abstract][Full Text] [Related]
14. How are ECG parameters related to cardiac magnetic resonance images? Electrocardiographic predictors of left ventricular hypertrophy and myocardial fibrosis in hypertrophic cardiomyopathy.
Dohy Z; Vereckei A; Horvath V; Czimbalmos C; Szabo L; Toth A; Suhai FI; Csecs I; Becker D; Merkely B; Vago H
Ann Noninvasive Electrocardiol; 2020 Sep; 25(5):e12763. PubMed ID: 32329134
[TBL] [Abstract][Full Text] [Related]
15. Potential role of vitamin D deficiency on Fabry cardiomyopathy.
Drechsler C; Schmiedeke B; Niemann M; Schmiedeke D; Krämer J; Turkin I; Blouin K; Emmert A; Pilz S; Obermayer-Pietsch B; Weidemann F; Breunig F; Wanner C
J Inherit Metab Dis; 2014 Mar; 37(2):289-95. PubMed ID: 24141790
[TBL] [Abstract][Full Text] [Related]
16. Cardiac remodeling in middle-aged endurance athletes: relation between signal-averaged electrocardiogram and LV mass.
Banks L; Al-Mousawy S; Altaha MA; Konieczny KM; Osman W; Currie KD; Connelly KA; Yan AT; Sasson Z; Mak S; Goodman JM; Dorian P
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H316-H322. PubMed ID: 33124882
[TBL] [Abstract][Full Text] [Related]
17. Role of cardiac imaging in Anderson-Fabry cardiomyopathy.
Serra W; Marziliano N
Cardiovasc Ultrasound; 2019 Jan; 17(1):1. PubMed ID: 30674321
[TBL] [Abstract][Full Text] [Related]
18. Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease.
Spinelli L; Pisani A; Sabbatini M; Petretta M; Andreucci MV; Procaccini D; Lo Surdo N; Federico S; Cianciaruso B
Clin Genet; 2004 Aug; 66(2):158-65. PubMed ID: 15253767
[TBL] [Abstract][Full Text] [Related]
19. Comparison of echocardiographic parameters in Fabry cardiomyopathy and light-chain cardiac amyloidosis.
Marek J; Palecek T; Magne J; Lavergne D; Boulogne C; Fadel BM; Jaccard A; Linhart A; Mohty D
Echocardiography; 2018 Nov; 35(11):1755-1763. PubMed ID: 30247786
[TBL] [Abstract][Full Text] [Related]
20. Absence of late gadolinium enhancement on cardiac magnetic resonance imaging in ventricular fibrillation and nonischemic cardiomyopathy.
Voskoboinik A; Wong MCG; Elliott JK; Costello BT; Prabhu S; Mariani JA; Kalman JM; Kistler PM; Taylor AJ; Morton JB
Pacing Clin Electrophysiol; 2018 Sep; 41(9):1109-1115. PubMed ID: 29931686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
